Synthesis and structure-activity optimization of azepane-containing derivatives as PTPN2/PTPN1 inhibitors
作者:Jiamin Zheng、Zhisen Zhang、Xiaoyu Ding、Deheng Sun、Lihua Min、Feng Wang、Sujing Shi、Xin Cai、Man Zhang、Alex Aliper、Feng Ren、Xiao Ding、Alex Zhavoronkov
DOI:10.1016/j.ejmech.2024.116390
日期:2024.4
The inhibition of PTPN2 and PTPN1 has emerged as an attractive approach to sensitize T cell anti-tumor immunity. Two small molecule inhibitors have been entered the clinic. Here we report the design and development of compound , a novel small molecule PTPN2/N1 inhibitor demonstrating nanomolar inhibitory potency, good oral bioavailability, and robust antitumor efficacy.
蛋白酪氨酸磷酸酶 PTPN2 和 PTPN1(也称为 PTP1B)与免疫细胞的许多细胞内信号传导通路有关。 PTPN2 和 PTPN1 的抑制已成为增强 T 细胞抗肿瘤免疫敏感性的一种有吸引力的方法。两种小分子抑制剂已进入临床。在这里,我们报告了化合物 的设计和开发,这是一种新型小分子 PTPN2/N1 抑制剂,具有纳摩尔级抑制效力、良好的口服生物利用度和强大的抗肿瘤功效。